Jazz Pharmaceuticals (JAZZ) EVP withholds 780 shares to cover tax obligations

Rhea-AI Filing Summary

Jazz Pharmaceuticals executive Samantha Pearce, EVP and Chief Commercial Officer, reported that 780 Ordinary Shares were withheld on 2026-08-05 at $261.62 per share to satisfy tax obligations from vesting of previously granted restricted stock units. After this tax-withholding disposition, she directly holds 47,131 Ordinary Shares.

Insider Trade Summary

Net Seller: 780 shares

Net Sell 1 txn

Insider Pearce Samantha

Role EVP, Chief Commercial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares F1	780	$261.62	$204K

Holdings After Transaction: Ordinary Shares — 47,131 shares (Direct)

Footnotes (1)

1. F1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Key Figures

Shares withheld for taxes: 780 Ordinary Shares Per-share value of withheld shares: $261.62 per share Shares held after transaction: 47,131 Ordinary Shares +1 more

4 metrics

Shares withheld for taxes 780 Ordinary Shares Withheld on 2026-08-05 to satisfy tax obligations from restricted stock unit vesting

Per-share value of withheld shares $261.62 per share Valuation used for the 780 Ordinary Shares withheld for tax obligations

Shares held after transaction 47,131 Ordinary Shares Direct holdings of Samantha Pearce following the tax-withholding disposition

Exercise-price-or-tax-liability shares 780 shares Total shares reported under code F for payment of tax liability

Key Terms

Ordinary Shares, restricted stock units, tax obligations

3 terms

Ordinary Shares financial

"The reported security is listed as Ordinary Shares of Jazz Pharmaceuticals."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

restricted stock units financial

"Shares withheld to satisfy tax obligations arising out of vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax obligations financial

"Shares withheld to satisfy tax obligations arising out of vesting of a portion of RSUs."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 06:01 PM Accepted by SEC EDGAR 08/07/2026 - 06:01 PM Learn about SEC filing dates

FAQ

What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Samantha Pearce?

Jazz Pharmaceuticals reported that 780 Ordinary Shares of executive Samantha Pearce were withheld on 2026-08-05. The shares were used to satisfy tax obligations arising from the vesting of previously granted restricted stock units.

At what price were Samantha Pearce’s JAZZ shares withheld for taxes?

The 780 Ordinary Shares of Jazz Pharmaceuticals associated with Samantha Pearce were valued at $261.62 per share. These shares were withheld specifically to cover tax obligations related to the vesting of restricted stock units.

How many Jazz Pharmaceuticals (JAZZ) shares does Samantha Pearce hold after this Form 4?

Following the reported tax-withholding transaction, Samantha Pearce directly holds 47,131 Ordinary Shares of Jazz Pharmaceuticals. This figure reflects her position after 780 shares were withheld to cover taxes from restricted stock unit vesting.

Was the JAZZ Form 4 transaction a market sale by Samantha Pearce?

No, the Form 4 shows no open-market sale by Samantha Pearce. Instead, 780 shares were withheld to satisfy tax obligations triggered by the vesting of previously granted restricted stock units.

What role does Samantha Pearce hold at Jazz Pharmaceuticals (JAZZ)?

Samantha Pearce serves as EVP, Chief Commercial Officer at Jazz Pharmaceuticals. The reported Form 4 transaction reflects shares withheld for tax obligations related to her equity compensation, not a discretionary market trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pearce Samantha

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/05/2026		F(1)		780	D	$261.62	47,131	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

	By: /s/Paz Dizon, as attorney in fact For: Samantha J. Pearce	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)